Article info

Download PDFPDF

Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent
Free

Authors

  1. Correspondence to:
    Dr M L Hetland
    DANBIO, Copenhagen University Hospital at Hvidovre, Department of Rheumatology 232, Kettegård Alle 30, DK 2650 Hvidovre, Denmark; merete.hetlanddadlnet.dk
View Full Text

Citation

Hjardem E, Hetland ML, Østergaard M, et al
Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of post-marketing use in Denmark and Norway: criteria are becoming less stringent

Publication history

  • Accepted December 28, 2004
  • First published January 7, 2005.
Online issue publication 
July 12, 2005

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.